当前位置:首页 - 行情中心 - 欧林生物(688319) - 财务分析

欧林生物

(688319)

  

流通市值:62.88亿  总市值:62.96亿
流通股本:4.05亿   总股本:4.06亿

欧林生物(688319)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润0.16亿元,每股收益0.05元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益93350.22万元,未分配利润-9589.40万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产180704.34万元,负债87354.12万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入588,858,464.45386,646,898.48226,277,670.0370,798,700.81
营业总成本569,996,827.89379,815,023.64244,503,957.28109,128,006.76
营业利润21,310,232.61519,948.51-31,743,943.17-28,310,589.67
利润总额22,303,700.361,447,270.84-30,719,171.37-27,295,829.82
净利润15,720,687.32-82,910.37-30,719,171.37-27,295,829.82
其他综合收益----
综合收益总额15,720,687.32-82,910.37-30,719,171.37-27,295,829.82
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计908,143,768.42899,689,104.91886,320,859.02884,224,118.91
非流动资产合计898,899,641.1807,888,722.38777,814,511.72709,913,157.08
资产总计1,807,043,409.521,707,577,827.291,664,135,370.741,594,137,275.99
流动负债合计595,593,540.91483,828,132.93484,905,191.18421,257,119.53
非流动负债合计277,947,646.99302,799,226.46286,712,420.53265,189,054.58
负债合计873,541,187.9786,627,359.39771,617,611.71686,446,174.11
归属于母公司股东权益合计924,679,134.42911,199,300.12881,429,945.65895,130,016.8
股东权益合计933,502,221.62920,950,467.9892,517,759.03907,691,101.88
负债和股东权益合计1,807,043,409.521,707,577,827.291,664,135,370.741,594,137,275.99
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计535,740,939.88353,170,918.84215,860,829.1691,177,236.11
经营活动现金流出小计545,472,150.28414,899,316.72273,691,670.36156,571,598.54
经营活动产生的现金流量净额-9,731,210.4-61,728,397.88-57,830,841.2-65,394,362.43
投资活动现金流入小计219,885,077.26137,500,725.6954,178,993.3510,018,657.53
投资活动现金流出小计443,819,279.08361,386,408.01222,692,798.2777,328,580.1
投资活动产生的现金流量净额-223,934,201.82-223,885,682.32-168,513,804.92-67,309,922.57
筹资活动现金流入小计206,823,147201,823,147152,363,14767,773,800
筹资活动现金流出小计110,915,776.9585,827,398.0152,349,266.813,820,739.95
筹资活动产生的现金流量净额95,907,370.05115,995,748.99100,013,880.1963,953,060.05
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-137,758,042.17-169,618,331.21-126,330,765.93-68,751,224.95
期末现金及现金等价物余额217,776,831.01185,916,541.97229,204,107.25286,783,648.23
最新报告期:2025-03-29
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
西南证券杜向阳0.050.120.202025-03-29
TOP↑